| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 13 Jan 2026 | 41 | 34% | 56% | 10% | 66% |
| 01 Jan 2025 - 30 Jun 2025 | 08 Jul 2025 | 32 | 57% | 36% | 7% | 43% |
| 01 Jul 2024 - 31 Dec 2024 | 08 Jan 2025 | 35 | 55% | 36% | 9% | 45% |
| 01 Jan 2024 - 30 Jun 2024 | 31 Jul 2024 | 32 | 56% | 39% | 5% | 44% |
| 01 Jul 2023 - 31 Dec 2023 | 11 Jan 2024 | 35 | 55% | 37% | 8% | 45% |
| 01 Jan 2023 - 30 Jun 2023 | 06 Jul 2023 | 39 | 54% | 35% | 11% | 46% |
| 01 Jul 2022 - 31 Dec 2022 | 11 Jan 2023 | 37 | 53% | 37% | 10% | 47% |
| 01 Jan 2022 - 30 Jun 2022 | 13 Jul 2022 | 38 | 51% | 39% | 10% | 49% |
| 01 Jul 2021 - 31 Dec 2021 | 13 Jan 2022 | 37 | 53% | 37% | 10% | 67% |
| 01 Jan 2021 - 30 Jun 2021 | 07 Jul 2021 | 35 | 53% | 38% | 9% | 71% |
| 01 Jul 2020 - 31 Dec 2020 | 12 Jan 2021 | 39 | 44% | 45% | 11% | 78% |
| 01 Jan 2020 - 30 Jun 2020 | 13 Jul 2020 | 41 | 37% | 52% | 11% | 88% |
| 01 Jul 2019 - 31 Dec 2019 | 14 Jan 2020 | 45 | 79% | 8% | 13% | 86% |
| 01 Jan 2019 - 30 Jun 2019 | 16 Jul 2019 | 47 | 31% | 51% | 18% | 95% |
| 01 Jul 2018 - 31 Dec 2018 | 10 Jan 2019 | 40 | 77% | 12% | 11% | 92% |
| 01 Jan 2018 - 30 Jun 2018 | 16 Jul 2018 | 31 | 55% | 38% | 7% | 83% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
As per our terms and conditions - unless otherwise stated in the Order, we will pay the contract price 60 (sixty) days after the month end date of the invoice
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Please send all disputes to ap-queries@ethypharm.com for consideration. We aim to respond to all disputes within 14 days.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Macarthys Laboratories Limited is a UK-based company that specializes in the research, development, and manufacture of pharmaceutical products. The company was founded in 1985 and has since become a leading player in the pharmaceutical industry.
Their sustainability program is focused on reducing their carbon footprint and promoting environmental sustainability. They have implemented initiatives such as reducing energy consumption, waste management, and using eco-friendly materials in their production processes.
Macarthys Laboratories Limited offers a wide range of products and services including research and development, contract manufacturing, and distribution of pharmaceutical products. They also provide consultation services to other pharmaceutical companies.
The key people at Macarthys Laboratories Limited include the CEO, Mr. John Macarthy, who has over 30 years of experience in the pharmaceutical industry. The company also has a team of experienced scientists, researchers, and technicians who ensure the quality and effectiveness of their products.
For more information about their products and services, you can visit their website at www.macarthyslabs.co.uk. Their registered office address is 12 High Street, London, UK. Macarthys Laboratories Limited is committed to providing high-quality pharmaceutical products while also promoting sustainability practices.
Proud of your payment record? Show your live score on your own site:
<iframe src="https://paymentcheck.co.uk/badge/00620024" width="240" height="72" style="border:0" title="PaymentCheck Score" loading="lazy"></iframe>